Success Metrics

Completion Rate
0%(0/10)
Active Trials
0(0%)
Terminated
10(100%)

Phase Distribution

Ph phase_3
8
80%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
8(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 10 finished

Non-Completion Rate

100.0%

10 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Terminated(10)

Detailed Status

Terminated10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (20.0%)
Phase 38 (80.0%)

Trials by Status

terminated10100%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_3

MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)

NCT00543816
terminatedphase_3

Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)

NCT00543751
terminatedphase_3

MK0767 and Metformin Combination Study (0767-028)

NCT00543738
terminatedphase_2

MK0767 in Type 2 Diabetes (0767-012)

NCT00543556
terminatedphase_2

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

NCT00703690
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00543816Phase 3

MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)

Terminated
NCT00543751Phase 3

Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)

Terminated
NCT00543738Phase 3

MK0767 and Metformin Combination Study (0767-028)

Terminated
NCT00543556Phase 2

MK0767 in Type 2 Diabetes (0767-012)

Terminated
NCT00703690Phase 2

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Terminated
NCT00543361Phase 3

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Terminated
NCT00547274Phase 3

Dyslipidemia in Type 2 Diabetes (0767-034)

Terminated
NCT00543491Phase 3

MK0767 and Sulfonylurea Combination Study (0767-027)

Terminated
NCT00543010Phase 3

MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

Terminated
NCT00543517Phase 3

Study A - MK0767 Monotherapy Study

Terminated

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10